Effects of Hydroxypropyl-Beta-Cyclodextrin on Cultured Brain Endothelial Cells

Effects of Hydroxypropyl-Beta-Cyclodextrin on Cultured Brain Endothelial Cells

The application of 2-hydroxypropyl-beta-cyclodextrin (HPBCD) in the treatment of the rare cholesterol and lipid storage disorder Niemann–Pick disease type C opened new perspectives in the development of an efficient therapy. Even if the systemic administration of HPBCD was found to be effective, its...

Full description

Bibliographic Details
Main Authors:	Szilvia Veszelka, Mária Mészáros, Gergő Porkoláb, Ágnes Rusznyák, Katalin Szászné Réti-Nagy, Mária A. Deli, Miklós Vecsernyés, Ildikó Bácskay, Judit Váradi, Ferenc Fenyvesi
Format:	Article
Language:	English
Published:	MDPI AG 2022-11-01
Series:	Molecules
Subjects:	blood–brain barrier 2-hydroxypropyl-beta-cyclodextrin endocytosis Niemann–Pick disease type C
Online Access:	https://www.mdpi.com/1420-3049/27/22/7738

Similar Items

Pharmacokinetic Properties of Fluorescently Labelled Hydroxypropyl-Beta-Cyclodextrin
by: Judit Váradi, et al.
Published: (2019-09-01)

Cellular Effects of Cyclodextrins: Studies on HeLa Cells
by: Ágnes Rusznyák, et al.
Published: (2022-02-01)

A marked paucity of granule cells in the developing cerebellum of the Npc1−/− mouse is corrected by a single injection of hydroxypropyl-β-cyclodextrin
by: S. Nusca, et al.
Published: (2014-10-01)

Intracerebroventricular Treatment with 2-Hydroxypropyl-β-Cyclodextrin Decreased Cerebellar and Hepatic Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Expression in Niemann–Pick Disease Type C Model Mice
by: Madoka Fukaura, et al.
Published: (2021-01-01)

Molecular Mind Games: The Medicinal Action of Cyclodextrins in Neurodegenerative Diseases
by: Susana Santos Braga
Published: (2023-04-01)

Cyclodextrin Complexation Improves the Solubility and Caco-2 Permeability of Chrysin
by: Ferenc Fenyvesi, et al.
Published: (2020-08-01)

Niemann Peak Disease Type A in Necropsy of the Liver of a Four-Month-Old Female with Fe-ver and Pancytopenia
by: Amer Yazdanparast, et al.
Published: (2021-05-01)

Cyclodextrins in Drug Delivery Systems and their Effects on Biological Barriers
by: Ádám Haimhoffer, et al.
Published: (2019-11-01)

Ezetimibe blocks the internalization of NPC1L1 and cholesterol in mouse small intestine
by: Chang Xie 谢畅, et al.
Published: (2012-10-01)

Vascular endothelial growth factor improves the therapeutic effects of cyclodextrin in Niemann-Pick type C mice
by: Min Seock Jeong, et al.
Published: (2019-09-01)

Localization of the murine Niemann-Pick C1 protein to two distinct intracellular compartments
by: William S. Garver, et al.
Published: (2000-05-01)

Different solubilizing ability of cyclodextrin derivatives for cholesterol in Niemann–Pick disease type C treatment
by: Yusei Yamada, et al.
Published: (2023-08-01)

Ezetimibe interferes with cholesterol trafficking from the plasma membrane to the endoplasmic reticulum in CaCo-2 cells
by: F. Jeffrey Field, et al.
Published: (2007-08-01)

Preparation and Physicochemical Properties of the Complex of Naringenin with Hydroxypropyl-β-Cyclodextrin
by: Jiping Wen, et al.
Published: (2010-06-01)

Inhibition of fatty acid amide hydrolase prevents pathology in neurovisceral acid sphingomyelinase deficiency by rescuing defective endocannabinoid signaling
by: Adrián Bartoll, et al.
Published: (2020-11-01)

Priapism associated with Niemann-Pick disease in a 15-year-old boy
by: M V Krishna Shetty, et al.
Published: (2011-01-01)

Niemann - Pick disease associated with hemophagocytic syndrome
by: Serap Karaman, et al.
Published: (2010-12-01)

Niemann - Pick disease associated with hemophagocytic syndrome
by: Serap Karaman, et al.
Published: (2010-12-01)

Effect of hydroxypropyl-β-cyclodextrin on the stability of cisapride in oral suspensions
by: Jutima Boonleang, et al.
Published: (2010-12-01)

A therapy with miglustat, 2-hydroxypropyl-ß-cyclodextrin and allopregnanolone restores splenic cholesterol homeostasis in Niemann-pick disease type C1
by: Anna-Maria Neßlauer, et al.
Published: (2019-06-01)

Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid
by: Benny Liu, et al.
Published: (2010-05-01)

Interaction of antitumor cytokine EMAP II with hydroxypropyl-beta-cyclodextrin
by: A. Malyna, et al.
Published: (2016-08-01)

Photostability of piroxicam in the inclusion complex with 2-hydroxypropyl-β-cyclodextrin
by: Nikolić Vesna D., et al.
Published: (2014-01-01)

The hydroxypropyl–β-cyclodextrin complexation of toltrazuril for enhancing bioavailability
by: Zhang L, et al.
Published: (2018-03-01)

Compound heterozygous Niemann-Pick Type C disease in the neonatal period
by: Özden Turan, et al.
Published: (2021-09-01)

The improved photostability of naproxen in the inclusion complex with 2-hydroxypropyl-β-cyclodextrin
by: Ilić-Stojanović Snežana S., et al.
Published: (2015-01-01)

Cholesterol efflux via HDL resecretion occurs when cholesterol transport out of the lysosome is impaireds⃞
by: Tamara A. Pagler, et al.
Published: (2007-10-01)

Pharmacological reversion of sphingomyelin‐induced dendritic spine anomalies in a Niemann Pick disease type A mouse model
by: Ana I Arroyo, et al.
Published: (2014-03-01)

Dental Treatment of Two Children with Niemann Pick Disease Type B Under General Anesthesia: Case Reports
by: Mustafa Sarp KAYA, et al.
Published: (2019-01-01)

Inclusion complex of tamibarotene with hydroxypropyl-β-cyclodextrin: Preparation, characterization, in-vitro and in-vivo evaluation
by: Ying Yang, et al.
Published: (2017-03-01)

Stability, Antioxidant Activity and Intestinal Permeation of Oleuropein Inclusion Complexes with Beta-Cyclodextrin and Hydroxypropyl-Beta-Cyclodextrin
by: Hui Liu, et al.
Published: (2022-08-01)

Effect of preparation methods on tosufloxacin tosylate/ hydroxypropyl-β-cyclodextrin inclusion complex
by: Jianfei Sun, et al.
Published: (2023-01-01)

Combinations of Piperine with Hydroxypropyl-β-Cyclodextrin as a Multifunctional System
by: Anna Stasiłowicz, et al.
Published: (2021-04-01)

Formation of inclusion complex of enrofloxacin with 2-hydroxypropyl-β-cyclodextrin
by: Yili Ding, et al.
Published: (2020-01-01)

Cholesterol lowering effects of mono-lactose-appended β-cyclodextrin in Niemann–Pick type C disease-like HepG2 cells
by: Keiichi Motoyama, et al.
Published: (2015-11-01)

Cyclodextrins and Iatrogenic Hearing Loss: New Drugs with Significant Risk
by: Mark A. Crumling, et al.
Published: (2017-11-01)

Characterization of an aryl piperazine/2-hydroxypropyl-β-cyclodextrin association, a complex with antidiabetic potential
by: R. Devine, et al.
Published: (2020-01-01)

Synthesis of multi-lactose-appended β-cyclodextrin and its cholesterol-lowering effects in Niemann–Pick type C disease-like HepG2 cells
by: Keiichi Motoyama, et al.
Published: (2017-01-01)

The susceptibility of cochlear outer hair cells to cyclodextrin is not related to their electromotile activity
by: Yingjie Zhou, et al.
Published: (2018-09-01)

Consensus clinical management guidelines for acid sphingomyelinase deficiency (Niemann–Pick disease types A, B and A/B)
by: Tarekegn Geberhiwot, et al.
Published: (2023-04-01)